Medivation Announces Participation at Upcoming Investor Conference
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 08/08/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following investor conference:
David Hung, M.D., president and chief executive officer, will present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference on Wednesday, August 15 at 8:00am Eastern Time at the Le Parker Meridien in New York City.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.08.2012 - 21:49 Uhr
Sprache: Deutsch
News-ID 173016
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 233 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Participation at Upcoming Investor Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
